Trials / Terminated
TerminatedNCT01944982
Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma
Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma.
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Hospital Infantil Universitario Niño Jesús, Madrid, Spain · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
To determine safety profile of immunotherapy with natural killer cells and activated expanded (NKAEs) after salvage chemotherapy in relapsed/refractory paediatric T cell lymphoblastic leukaemia and lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Expanded haploidentical natural killer cells (NKAEs) |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2013-09-18
- Last updated
- 2016-12-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01944982. Inclusion in this directory is not an endorsement.